Keyphrases
Tyrosine Kinase
100%
Oncogene
100%
ACK1
100%
Histone Demethylase
100%
Mammary Tumor
100%
KDM3A
100%
HOXA1
100%
Estrogen Receptor
40%
Receptor Tyrosine Kinase
30%
Dasatinib
30%
Tamoxifen Resistance
30%
AIM-100
30%
Dimethyl
20%
Regulated Genes
20%
Coactivator
20%
Heregulin
20%
Epigenetics
10%
Tyrosine
10%
Overexpression
10%
Knockdown
10%
Breast Cancer Patients
10%
Novel Therapeutics
10%
Human Epidermal Growth Factor Receptor 2 (HER2)
10%
Poor Prognosis
10%
Estrogen
10%
Small Molecule Inhibitors
10%
Estrogen Receptor Status
10%
Gene Transcription
10%
New Therapeutics
10%
Breast Tumor
10%
Transcriptional Repression
10%
Hormone Therapy
10%
Estrogen Receptor-positive Breast Cancer
10%
Drug Resistance
10%
Evolutionary
10%
HER2 Receptor
10%
Therapeutic Avenues
10%
Intrinsic Resistance
10%
Selective Estrogen Receptor Modulators
10%
Tamoxifen Therapy
10%
Epigenetic Marks
10%
TNK2
10%
H3K9me3
10%
H3K9 Methylation
10%
H3K9 Demethylase
10%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%
Estrogen Receptor
100%
Oncogene
100%
Demethylase
100%
Histone
100%
Dasatinib
42%
Epigenetics
28%
Upregulation
14%
Tyrosine
14%
Drug Resistance
14%
Small Molecule
14%
Genetic Transcription
14%
Methylation
14%
Non-Receptor Tyrosine Kinase
14%
Evolution
14%
Medicine and Dentistry
Protein Tyrosine Kinase
100%
Oncogene
100%
Breast Tumor
100%
Tamoxifen
100%
Histone Demethylase
100%
Estrogen Receptor
71%
Dasatinib
42%
Neu Differentiation Factor
28%
Upregulation
14%
Drug Resistance
14%
Breast Cancer
14%
Genetic Transcription
14%
Hormone Therapy
14%
Methylation
14%
Estrogen Receptor Positive Breast Cancer
14%
Evolution
14%
Selective Estrogen Receptor Modulator
14%